Invivyd IVVD
NASDAQ IVVD
$0.83 +0.00 (+0.00%)
At close: Sep 4, 2026 · 4:00 PM EDT

Invivyd (IVVD) Receivables (2023 - 2026)

Invivyd's (IVVD) quarterly Receivables came in at $11.7 million in Q2 2026, up 32.63% on a YoY basis from $8.8 million in Q2 2025, and down 19.95% quarter-over-quarter from $14.6 million in Q4 2025.

Analysis

Invivyd (IVVD) Receivables (2023 - 2026) Analysis & Trends

Invivyd (IVVD) has reported Receivables for 4 consecutive years, with $11.7 million the latest figure, recorded in Q2 2026.

  • For the quarter ending Q2 2026, Receivables rose 32.63% year-over-year to $11.7 million; the trailing twelve-month figure through Jun 2026 stood at $11.7 million (up 32.63% YoY), and the FY2025 full-year result was $14.6 million, up 30.67% from the prior year.
  • Receivables eased to $11.7 million in Q2 2026 per IVVD's latest filing, from $14.6 million in the prior quarter.
  • Across five years, Receivables topped out at $14.6 million in Q4 2025 and bottomed at $933000.0 in Q4 2023.
  • Historically, Receivables has averaged $8.7 million across 4 years, with a median of $8.8 million in 2025.
  • The sharpest annual moves came in 2024 and 2025: Receivables surged 1097.11% in 2024, then climbed 17.02% in 2025.
  • Over 4 years, Receivables stood at $933000.0 in 2023, then soared by 1097.11% to $11.2 million in 2024, then soared by 30.67% to $14.6 million in 2025, then retreated by 19.95% to $11.7 million in 2026.
  • According to Business Quant data, Receivables over the past three periods registered $11.7 million, $14.6 million, and $10.1 million for Q2 2026, Q4 2025, and Q3 2025 respectively.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Receivables (Qtr)
1 Amgen 236.37 Bn 222.38 Bn 7.24 Bn 10.23 Bn
2 Gilead Sciences 187.38 Bn 184.12 Bn 6.22 Bn 5.90 Bn
3 Vertex Pharmaceuticals 138.36 Bn 130.51 Bn 2.84 Bn 2.13 Bn
4 Regeneron Pharmaceuticals 85.09 Bn 77.10 Bn 3.93 Bn 6.57 Bn
5 Argenx Se 63.93 Bn 58.75 Bn 1.37 Bn 1.93 Bn
6 Moderna 58.07 Bn 52.94 Bn 52.00 Mn 160.00 Mn
7 Alnylam Pharmaceuticals 35.59 Bn 32.28 Bn 992.69 Mn 912.74 Mn
8 Biogen 32.63 Bn 31.34 Bn 1.96 Bn 1.89 Bn
9 Insmed 27.57 Bn 26.41 Bn 358.27 Mn 215.33 Mn
10 Invivyd 244.65 Mn 84.57 Mn 13.01 Mn 11.68 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 11.68 Mn
Dec 31, 2025 14.60 Mn
Sep 30, 2025 10.13 Mn
Jun 30, 2025 8.81 Mn
Mar 31, 2025 8.75 Mn
Dec 31, 2024 11.17 Mn
Sep 30, 2024 8.66 Mn
Jun 30, 2024 3.54 Mn
Dec 31, 2023 933,000.00